Aggressive vs. conservative phototherapy for infants with extremely low birth weight

New England Journal of Medicine

Volumn 359, Issue 18, 2008, Pages 1885-1896

  Morris, Brenda H ^a   Oh, William ^b   Tyson, Jon E ^a   Stevenson, David K ^c   Phelps, Dale L ^d   O'Shea, T Michael ^e   McDavid, Georgia E ^a   Perritt, Rebecca L ^f   Van Meurs, Krisa P ^c   Vohr, Betty R ^b   Grisby, Cathy ^h   Yao, Qing ^f   Pedroza, Claudia ⁱ   Das, Abhik ^g   Poole, W Kenneth ^f   Carlo, Waldemar A ^j   Duara, Shahnaz ^k   Laptook, Abbot R ^b   Salhab, Walid A ^l   Shankaran, Seetha ^m   Poindexter, Brenda B ⁿ   Fanaroff, Avroy A ^o   Walsh, Michele C ^o   Rasmussen, Maynard R ^p   Stoll, Barbara J ^q   Cotten, C Michael ^r   Donovan, Edward F ^h   Ehrenkranz, Richard A ^s   Guillet, Ronnie ^d   Higgins, Rosemary D ^t   more..

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f RTI INTERNATIONAL   (United States)

^g University of Cincinnati ^*

^h UNIVERSITY OF CINCINNATI   (United States)

ⁱ UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^m WAYNE STATE UNIVERSITY   (United States)

ⁿ INDIANA UNIVERSITY   (United States)

^o CASE WESTERN RESERVE UNIVERSITY   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q EMORY UNIVERSITY   (United States)

^r DUKE UNIVERSITY   (United States)

^s YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHOTOTHERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 55249101226     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0803024     Document Type: Article

References (41)

1. Bratlid D. How bilirubin gets into the brain. Clin Perinatol 1990;17:449-65.
2. Cashore WJ. The neurotoxicity of bilirubin. Clin Perinatol 1990;17:437-47.
3. Lucey JF. Bilirubin and brain damage - a real mess. Pediatrics 1982;69:381-2.
4. Watchko JF, Oski FA. Kernicterus in preterm newborns: past, present, and future. Pediatrics 1992;90:707-15.
5. Boggs TR Jr, Hardy JB, Frazier TM. Correlation of neonatal serum total bilirubin concentrations and developmental status at age eight months: a preliminary report from the Collaborative Project. J Pediatr 1967;71:553-60.
6. Scheidt PC, Mellits ED, Hardy JB, Drage JS, Boggs TR. Toxicity to bilirubin in neonates: infant development during first year in relation to maximum neonatal serum bilirubin concentration. J Pediatr 1977;91:292-7.
7. van de Bor M, van Zeben-van der Aa TM, Verloove-Vanhorick SP, Brand R, Ruys JH. Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age: results of a national collaborative survey. Pediatrics 1989;83:915-20.
8. Oh W, Tyson JE, Fanaroff AA, et al. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 2003;112:773-9.
9. O'Shea TM, Dillard RG, Klinepeter KL, Goldstien DJ. Serum bilirubin levels, intracranial hemorrhage, and the risk of developmental problems in very low birth weight neonates. Pediatrics 1992;90:888-92.
10. Graziani LJ, Mitchell DG, Kornhauser M, et al. Neurodevelopment of preterm infants: neonatal neurosonographic and serum bilirubin studies. Pediatrics 1992;89:229-34.
11. Yeo KL, Perlman M, Hao Y, Mullaney P. Outcomes of extremely premature infants related to their peak serum bilirubin concentrations and exposure to phototherapy. Pediatrics 1998;102:1426-31.
12. Gopinathan V, Miller NJ, Milner AD, Rice-Evans CA. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett 1994;349:197-200.
13. Maisels MJ. Neonatal hyperbilirubinemia. In: Klaus MH, Fanaroff AA, eds. Care of the high-risk neonate. 5th ed. Philadelphia: W.B. Saunders, 2001:324-62.
14. Brown AK, Kim MH, Wu PYK, Bryla DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 1985;75:393-400.
15. Scheidt PC, Bryla DA, Nelson KB, Hirtz DG, Hoffman HJ. Phototherapy for neonatal hyperbilirubinemia: six-year follow-up of the National Institute of Child Health and Human Development clinical trial. Pediatrics 1990;85:455-63.
16. Lipsitz PJ, Gartner LM, Bryla DA. Neonatal and infant mortality in relation to phototherapy. Pediatrics 1985;75:Suppl:422-6.
17. Sinclair JC, Bracken MB, eds. Effective care of the newborn infant. Oxford, England: Oxford University Press, 1992:532.
18. Ahlfors CE. Unbound bilirubin associated with kernicterus: a historical approach. J Pediatr 2000;137:540-4.
19. Jadad AR, Enkin MW. Randomized controlled trials: questions, answers and musings. 2nd ed. Malden, MA: Blackwell Publishing, 2007:13-5.
20. Vohr BR, Wright LL, Poole WK, McDonald SA. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998. Pediatrics 2005;116:635-43.
21. Bayley N. Bayley Scales of infant development II. New York: Psychological Corporation, 1993.
22. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD. Intensive care for extreme prematurity - moving beyond gestational age. N Engl J Med 2008;358:1672-81.
23. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997;39:214-23.
24. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6.
25. Dixon DO, Simon R. Bayesian subset analysis. Biometrics 1991;47:871-81. [Erratum, Biometrics 1994;50:322.]
26. Simon RM, Dixon DO, Freidlin B. A Bayesian model for evaluating specificity of treatment effects in clinical trials. In: Thall PF, ed. Recent advances in clinical trial design and analysis. Norwell, MA: Kluwer Academic, 1995:155-75.
27. Simon R. Bayesian subset analysis: application to studying treatment-by-gender interactions. Stat Med 2002;21:2909-16.
28. Berry DA. Bayesian clinical trials. Nat Rev Drug Discov 2006;5:27-36.
29. Spiegelhalter DJ, Myles JP, Jones DR, Abrams, KR. An introduction to Bayesian methods in health technology assessment. BMJ 1999;319:508-12.
30. R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2007.
31. Hack M, Wilson-Costello D, Friedman H, Taylor GH, Schluchter M, Fanaroff AA. Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992-1995. Arch Pediatr Adolesc Med 2000;154:725-31.
32. Lilford RJ, Thornton JG, Braunholtz D. Clinical trials and rare diseases: a way out of a conundrum. BMJ 1995;311:1621-5.
33. Brophy JM, Joseph L. Placing trials in context using Bayesian analysis: GUSTO revisited by Reverend Bayes. JAMA 1995;273:871-5.
34. DeMets DL, Pocock SJ, Julian DG. The agonising negative trend in monitoring of clinical trials. Lancet 1999;354:1983-8.
35. Oxman A, Guyatt G. Summarizing the evidence: when to believe a subgroup analysis. In: Guyatt G, Drummond R, eds. Users' guides to the medical literature: a manual for evidence-based clinical practice. Chicago: AMA Press, 2002:553-65.
36. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine - reporting of subgroup analyses in clinical trials. N Engl J Med 2007;357:2189-94.
37. Tozzi E, Tozzi-Ciancarelli MG, Di Giulo A, et al. In vitro and in vivo effects of erythrocyte phototherapy on newborns. Biol Neonate 1989;56:204-9.
38. Sisson TR. Photodegradation of riboflavin in neonates. Fed Proc 1987;46:1883-5.
39. Vreman HJ, Wong RJ, Stevenson DK. Phototherapy: current methods and future directions. Semin Perinatol 2004;28:326-33.
40. Hintz SR, Cheong WF, van Houten JP, Stevenson DK, Benaron DA. Bedside imaging of intracranial hemorrhage in the neonate using light: comparison with ultrasound, computed tomography, and magnetic resonance imaging. Pediatr Res 1999;45:54-9.
41. Wong RJ, Bhutani VK, Vreman HJ, Stevenson DK. Tin mesoporphyrin for the prevention of severe neonatal hyperbilirubinemia. NeoReviews 2007;8(2):e77-e84.